Atrial fibrillation, cognitive impairment, and neuroimaging
- PMID: 26607820
- PMCID: PMC4841716
- DOI: 10.1016/j.jalz.2015.08.164
Atrial fibrillation, cognitive impairment, and neuroimaging
Abstract
Introduction: The objective of our study was to investigate cross-sectional associations of atrial fibrillation with neuroimaging measures of cerebrovascular disease and Alzheimer's disease and their interactions with mild cognitive impairment (MCI).
Methods: Magnetic resonance imaging scans of individuals from a population-based study were analyzed for infarctions, total gray matter, and hippocampal and white matter hyperintensity volumes. A subsample underwent positron emission tomography imaging.
Results: Atrial fibrillation was associated with infarctions and lower total gray matter volume. Compared with subjects with no atrial fibrillation and no infarction, the odds ratio (95% confidence intervals) for MCI was 2.99 (1.57-5.70; P = .001) among participants with atrial fibrillation and infarction, 0.90 (0.45-1.80; P = .77) for atrial fibrillation and no infarction, and 1.50 (0.96-2.34; P = .08) for no atrial fibrillation and any infarction.
Discussion: Participants with both atrial fibrillation and infarction are more likely to have MCI than participants with either infarction or atrial fibrillation alone.
Keywords: Alzheimer's disease; Atrial fibrillation; Cerebrovascular disease; Mild cognitive impairment; Stroke.
Copyright © 2016 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042–6. - PubMed
-
- Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS, et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer’s dementia. Heart Rhythm. 2010;7:433–7. - PubMed
-
- Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke. 1997;28:316–21. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AG041851/AG/NIA NIH HHS/United States
- R01 AG029550/AG/NIA NIH HHS/United States
- P50 AG016574/AG/NIA NIH HHS/United States
- U01 HL096917/HL/NHLBI NIH HHS/United States
- U01 AG024904/AG/NIA NIH HHS/United States
- U19 AG010483/AG/NIA NIH HHS/United States
- R01 AG040042/AG/NIA NIH HHS/United States
- R01 AG011378/AG/NIA NIH HHS/United States
- R01 AG037551/AG/NIA NIH HHS/United States
- R01 AG032306/AG/NIA NIH HHS/United States
- R01 AG043392/AG/NIA NIH HHS/United States
- U01 AG06786/AG/NIA NIH HHS/United States
- P50 AG044170/AG/NIA NIH HHS/United States
- R00 AG037573/AG/NIA NIH HHS/United States
- U01 AG006786/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical